Dunn Regulatory Associates Sold to Acacium Group, a Portfolio Company of Onex
Dunn Regulatory Associates (DRA) is a U.S.-based life sciences and regulatory affairs consulting company that serves a diverse, global client base of pharmaceutical, biotech, and medical device companies. DRA’s comprehensive regulatory services include regulatory strategy, medical writing, regulatory publishing, and U.S. Agent services. Using an experience-based approach that integrates scientific expertise, business acumen, and regulatory strategy, DRA streamlines product development from discovery to market. DRA’s expert consultants are U.S. and EU strategists, who have a proven track record of resolving complex regulatory situations.